Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Un-audited Financial Results ....
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has informed the stock exchanges that a Board of Directors meeting is scheduled for Wednesday, August 13, 2025, at its registered office in Hyderabad. The main agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025. The trading window for designated persons and their relatives has already been closed from July 1, 2025, and will reopen 48 hours after the results are declared. No financial figures or business details have been disclosed in this filing — it is purely a procedural intimation ahead of the results announcement.
This is a routine regulatory disclosure with no direct impact on shareholders. Investors should watch the actual Q1FY26 results due on August 13, 2025, for any meaningful insight into the company's revenue, profitability, and margins. The closed trading window signals that insiders cannot trade until the results are published.